Data updated: May 26, 2026
HYDROCODONE BITARTRATE AND CHLORPHENIRAMINE MALEATE (chlorpheniramine maleate)
Respiratory
Approved 2015-01-27
2
Indications
--
Phase 3 Trials
11
Years on Market
Details
- Status
- Discontinued
- First Approved
- 2015-01-27
- Routes
- ORAL
- Dosage Forms
- SOLUTION
Companies
Website: ↗
HYDROCODONE BITARTRATE AND CHLORPHENIRAMINE MALEATE Approval History
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Original
New Indication
New Form
Label Update
3 FDA actions from 2015 to 2023
Dec 2023 SUPPL
Label · Labeling
Jun 2017 ORIGINAL
Update
Jan 2015 ORIGINAL
Update
What HYDROCODONE BITARTRATE AND CHLORPHENIRAMINE MALEATE Treats
2 FDA approvalsOriginally approved for its first indication in 2015 . Covers 2 distinct patient populations.
- Other (2)
Other
(2 approvals)- • Approved indication (Jan 2015)
- • Approved indication (Jun 2017)
🔬
Pro Active Pipeline
Ongoing clinical trials by development phase
Loading...
⭐
Pro Key Completed Trials
Completed studies with published results, ranked by significance
Loading...
📊
Trial Timeline
Full development history with FDA approval milestones
|
Loading...
Understanding FDA Approval Types
| Count | Type | What it means |
|---|---|---|
| - | ORIG | Original approval - drug first enters market |
| - | SUPPL - Efficacy | New indication (new disease/condition approved) |
| - | SUPPL - Labeling | Label text changes (warnings, dosing updates) |
| - | SUPPL - Manufacturing | Production changes (new facility) |
| - | SUPPL - Chemistry | Formulation changes (new dosage strength) |
Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.
HYDROCODONE BITARTRATE AND CHLORPHENIRAMINE MALEATE FDA Label Details
Track HYDROCODONE BITARTRATE AND CHLORPHENIRAMINE MALEATE with TheraRadar Pro
Watchlist alerts, full database access, CSV exports across 14,000+ drugs.
Data Sources
Data sourced from official FDA and NIH databases. Click links to verify on original sources.